Digital Self-Assessment Tool for Neuromyelitis Optica

Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

Recruiting N/A Interventional Study
Neuromyelitis Optica
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
103 (estimated)
Sponsor
Ad scientiam · Other
Who this trial is looking for

This trial is looking for adults with Neuromyelitis Optica Spectrum Disorder (NMOSD) to test a digital self-assessment tool. Participants will use a smartphone app to check their symptoms from home.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am over 18 years old.
  • I have NMOSD diagnosed according to specific criteria.
  • I have been on the same NMOSD treatment for at least 6 months.
  • I have no evidence of relapse in the past 3 months.
  • I can use a smartphone.
  • I own a personal smartphone with a recent version.
  • I can read and understand the language of the app.

You may not be able to join if

  • I have another neurological or psychiatric disorder.
  • I am pregnant or nursing.
  • I am bedridden or have very limited daily activity.
  • I have current drug or alcohol abuse issues.
  • I have participated in another clinical study in the last 30 days.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
NMOSDCopilot is a digital tool developed for the self-assessment of Neuromyelitis Optica Spectrum Disorder symptoms that impact patients' functioning and quality of life. It has been co-designed with the help of patient advocacy groups, NMOSD patients and medical experts. It includes a smartphone-based application for patients, connected to a web portal developed for healthcare professionals (HCSP…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Aged over 18 years old * NMOSD as defined by the 2015 international consensus diagnostic criteria (AQP4+ only) * With NMOSD treatment (treatment must be unchanged since 6 months before enrollment, and 1 month for analgesics, antidepressants, neuroleptics) * EDSS =\< 7 * With n…
Contacts

Dr Levy

617-726-7565

mlevy11@mgh.harvard.edu

CONTACT